This $250,000 is the third (of four) payment of our $1 Million Grant for the project “Onc-201 for DIPG and High Grade Gliomas with the H3 K27M mutation!”.  This exciting project allows patients to get access to Onc-201 under compassionate use, while being closely monitored for both side effects and efficacy.  So far, 82 patients have been treated under this grant, at 32 hospitals.  These patients would not have received this drug without our grant.

 

This grant is a collaborative effort between the Musella Foundation, The Cure Starts Now Foundation, Dragon Master Foundation and the Finn Family Foundation.  A special thank to Lisa Ward for helping bring the brain tumor community together on this project!